Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Sarcoma × milademetan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Recurrence 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Breast Neoplasms 1

Interventions

Doxorubicin 13 Cyclophosphamide 9 Gemcitabine 8 Filgrastim 8 pazopanib 7 Radiotherapy 7 Ifosfamide 7 Cisplatin 7 Docetaxel 6 Radiation 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Trabectedin 4 Magnetic Resonance Spectroscopy 4 Celecoxib 4 Busulfan 4 sargramostim 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Neoadjuvant Therapy 3 Dexrazoxane 3 Cryosurgery 3 Blotting, Western 3 temsirolimus 2 pembrolizumab 2 ixabepilone 2 ganitumab 2 fluoromisonidazole 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04979442 2025-01-14

MANTRA

Rain Oncology Inc

Phase 3 Terminated

175 enrolled 16 charts

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡